SEARCH

SEARCH BY CITATION

References

  • 1
    Adachi K, Kohara T, Nakano N et al. Design, synthesis, and structure-activity relationships of 2-substituted-2-amino-1,3-propanediols: discovery of a novel immunosuppressant, FTY720. Bioorg Med Chem 1995; 5: 853.
  • 2
    Fujita T, Inoue K, Yamamoto S et al. Fungal metabolites. Part II. A potent immunosuppressive activity found in Isaria Sinclairii metabolite. J Antibiot (Tokyo) 1994; 47: 208.
  • 3
    Suzuki S, Enosawa S, Kakefunda T et al. A novel immunosuppressant, FTY720, with a unique mechanism of action, induces long-term graft acceptance in rat and dog allotransplantation. Transplantation 1996; 61: 200205.
  • 4
    Hoshino Y, Suzuki C, Ohtsuki M, Masabuchi Y, Amano Y, Chiba K. FTY720, a novel immunosuppressant possessing unique mechan-isms. II. Long-term graft survival induction in rat heterotopic cardiac allografts and synergistic effect in combination with cyclosporine A. Transplant Proc 1996; 28: 10601061.
  • 5
    Mitsusada M, Suzuki S, Kobayashi E, Enosawa S, Kakefuda T, Miyata M. Prevention of graft rejection and graft-versus-host reaction by a novel immunosuppressant, FTY720, in rat small bowel transplantation. Transpl Int 1997; 10: 343349.
  • 6
    Suzuki T, Shimamura T, Jin MB et al. Dose-dependent study of a novel immunosuppressant, FTY720, with the canine renal allograft transplantation model. Transplant Proc 1999; 31: 12081209.
  • 7
    Furukawa H, Suzuki T, Jin MB et al. Prolongation of canine liver allograft survival by a novel immunosuppressant, FTY720. Transplantation 2000; 69: 235241.
  • 8
    Troncoso P, Stepkowski SM, Wang ME et al. Prophylaxis of acute renal allograft rejection using FTY720 in combination with sub-therapeutic doses of cyclosporine. Transplantation 1999; 67: 145151.
  • 9
    Kawaguchi T, Hoshino Y, Rahman F et al. FTY720, a novel immunosuppressant possessing unique mechanisms. III. Synergistic prolongation of canine renal allograft survival in combination with cyclosporine A. Transplant Proc 1996; 28: 10621063.
  • 10
    Suzuki S. , FTY: Mechanism of action and its effect on organ transplantation (review). Transplant Proc 1999; 31: 27792882.
  • 11
    Wang ME, Tejpal N, Qu X et al. Immunosuppressive effects of FTY720 alone or in combination with cyclosporine and/or sirolimus. Transplantation 1998; 65: 899905.
  • 12
    Nikolova Z, Hof A, Baumlin Y, Hof RP. The peripheral lymphocyte count predicts graft survival in DA to Lewis heterotopic heart transplantation treated with FTY720 and RAD. Transplantation 2000; 69: S194.
  • 13
    Diaz-Romero J, Beerli C, Caballero V, Weckbecker G. Time course of leucocyte subsets in rat peripheral blood after single treatment with FTY720. Transplantation 2000; 69: S194.
  • 14
    Quesniaux V, Fullard L, Arendse H et al. A novel immunosuppressant, FTY720, induces peripheral lymphodepletion of both T- and B cells and immunosuppression in baboons. Transpl Immunol 1999; 7: 149157.
  • 15
    Chiba K, Yanagawa Y, Masubuchi Y et al. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing. J Immunol 1998; 160: 50375044.
  • 16
    Suzuki S, Li XK, Enosawa S, Shinomiya T. A new immunosuppressant, FTY720, induces bcl-2-associated apoptotic cell death in human lymphocytes. Immunology 1996; 89: 518523.
  • 17
    Shinomiya T, Li XK, Amemiya H, Suzuki S. An immunosuppressive agent, FTY720, increases intracellular concentration of calcium ion and induces apoptosis in HL-60. Immunology 1997; 91: 594600.
  • 18
    Chiba K, Yanagawa Y, Kataoka H, Kawaguchi T, Ohtsuki M, Hoshino Y. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing. Transplant Proc 1999; 31: 12301233.
  • 19
    Yanagawa Y, Sugahara K, Kataoka H et al. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats: II. FTY720 prolongs skin allograft survival by decreasing T cell infiltration into grafts but not cytokine production in vivo. J Immunol 1998; 160: 54935499.
  • 20
    Brinkmann V, Pinschewer D, Feng L, Chen S. FTY720: Altered lymphocyte traffic results in allograft protection. Transplantation 2001; 72: 764769.
  • 21
    Migoya E, Marino M, Choudhury S et al. Dose selection by prediction of human oral clearance of FTY 270 using interspecies scaling. Transplantation 1999; 67: S153.
  • 22
    Nashan B, Lücker PW, Mayer T, Choudhury S, Skerjanec A, Kraus G, Neumayer H-H. First human trial of FTY720, a novel immunomodulator, in stable renal transplant patients. J Am Soc Nephrol 2002; 13: 10731083.
  • 23
    Nikolova Z, Hof A, Baumlin Y, Hof RP. Efficacy of SDZ RAD compared with CsA mono therapy and combined RAD/FTY720 treatment in a murine cardiac allotransplantation model. Transpl Immunol 2001; 9: 4349.
  • 24
    Pinschewer DD, Ochsenbein AF, Odermatt B, Brinkmann V, Hengartner H, Zinkernagel RM. FTY720 immunosuppression impairs effector T cell peripheral homing without affecting induction, expansion, and memory. J Immunol 2000; 164: 57615770.